Infinity Pharmaceuticals: Q4 Earnings Insights


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Shares of Infinity Pharmaceuticals (NASDAQ:INFI) decreased in after-market trading after the company reported Q4 results.

Quarterly Results

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Earnings per share were up 15.00% over the past year to ($0.17), which missed the estimate of ($0.16).

Revenue of $436,000 higher by 41.56% from the same period last year, which beat the estimate of $280,000.

Looking Ahead

Infinity Pharmaceuticals hasn't issued any earnings guidance for the time being.

Infinity Pharmaceuticals hasn't issued any revenue guidance for the time being.

How To Listen To The Conference Call


Wall Street Vet Reveals $9 Options Secret

Tired of tiny stock gains? This 40-year insider is spilling the beans on how to turn small investments into 600% returns. Get his proven options strategy in a FREE webinar.—Register now – seats are limited!


Date: Mar 16, 2021

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/24t7wsio

Price Action

52-week high: $5.98

52-week low: $0.60

Price action over last quarter: Up 130.40%

Company Profile

Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Posted In: EarningsBZI-Recaps